Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 9/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 5/20 | 0.34 |
| ▸ | FYN | P06241 | 2/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | ATR | Q13535 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18654405 | 0.82 | TGFBR1 (0.39) | TGFBR1F2F10PRSS1PRSS2 | |
| SCHEMBL18655184 | 0.81 | NTRK1 (0.33) | TGFBR1CHRM4NTRK1FYN | |
| SCHEMBL18654744 | 0.80 | TGFBR1 (0.35) | TGFBR1CHRM4NTRK1FYNIRAK4 | |
| SCHEMBL18654758 | 0.80 | TGFBR1 (0.43) | TGFBR1F2F10PRSS1PRSS2 | |
| SCHEMBL14897192 | 0.78 | TGFBR1 (0.46) | TGFBR1CHRM4NTRK1ATR | |
| SCHEMBL18654570 | 0.76 | TGFBR1 (0.42) | TGFBR1CHRM4NTRK1IRAK4ATR | |
| SCHEMBL14896955 | 0.76 | TGFBR1 (0.44) | TGFBR1NTRK1ATR | |
| SCHEMBL14896756 | 0.76 | ATR (0.46) | TGFBR1F2F10PRSS1PRSS2 | |
| SCHEMBL14897194 | 0.76 | ATR (0.44) | TGFBR1F2F10PRSS1PRSS2 | |
| SCHEMBL16193096 | 0.75 | TGFBR1 (0.49) | TGFBR1F2F10PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2768509-B1 | SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS | GLAXOSMITHKLINE LLC (US) | 2017-03-22 | — | — | EP | disclosed |